Doral

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Type 2 diabetes3 trials
• Coronary artery disease1 trial
• High blood pressure1 trial

Phase

• Phase 33 trials
• Phase 22 trials
• Phase 11 trial

Status

• Completed3 trials
• Not yet recruiting3 trials

Lead sponsor

• AstraZeneca5 trials
• DalCor Pharmaceuticals1 trial

Running trials

• Recruiting

  A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  NCT07784270· Phase 3· AstraZeneca· Source

• Recruiting

  A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

  NCT07664553· Phase 3· AstraZeneca· Source

• Recruiting

  Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

  NCT05918861· Phase 3· DalCor Pharmaceuticals· Source

  Contact: David Kallend, MBBS

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 2 diabetes2 recruiting
• Coronary artery disease1 recruiting
• Obesity1 recruiting

Closed trials

• Completed

  Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

  NCT06851858· Phase 2· AstraZeneca· Source

• Completed

  Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124

  NCT05459688· Phase 2· AstraZeneca· Source

• Completed

  A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis Patients

  NCT04483947· Phase 1· AstraZeneca· Source